Eoflow invests 18B won in Eopump production facility

Eoflow announced a 18 billion won investment in facilities for in-house production of the Eopump, a core component of its wearable insulin pump, including remodeling a new factory and building an automated line in Gwangju, Gyeonggi Province.

“이오플로우는 6일 웨어러블 인슐린 펌프의 핵심부품인 이오펌프 생산시설에 180억원 규모의 투자를 진행한다고 밝혔다.”etoday.co.kr

• 1 source
• etoday.co.kr[BioS]이오플로우, 180억 설비 투자.."이오펌프 자체 생산" - 이투데이Sep 6, 2021

Summarized from public sources; check the original articles before acting on it.